Our findings reveal a significant positive correlation between ST6GALNAC1, an enzyme implicated in the synthesis of tumor-associated glycans, and MUC1, a mucin glycoprotein frequently dysregulated in cancer. Here, ST6GALNAC1 is linked to cancer.